Popular Articles

Advanced Technologies Pump Growth Into European Cardiac Rhythm Management Market, Affirms Frost & Sullivan, UK
The incidence of cardiovascular disease is rising due to factors such as ageing, obesity, smoking and other cardiac ailments. Each year cardiovascular diseases cause over 4.3 million deaths, accounting for 48 per cent of all mortalities in Europe.
generic viagra online
Overhaul Of Immune Response Modelling Following Cell Division Finding
Research at the Walter and Eliza Hall Institute into the mechanics of how two types of white blood cells grow and die is fundamentally changing the development of computer models that are used to predict how immune system cells respond to a pathogenic threat.
News of the day
Improving The Biomarker Pipeline For Early Cancer Detection
Several statistical and biological issues need to be addressed in order to improve biomarker identification for early detection of cancer, according to a commentary published online July 2 in the Journal of the National Cancer Institute.
Mental Health

Medical Study Establishes First-Ever Long-Term Benefits For Macular Degeneration Sufferers Using Macular Health Vitamin Supplement

According to the World Health Organization (WHO), age-related macular degeneration (AMD) ranks third as a cause of visual impairment. It is the primary cause of visual impairment in industrial countries with a blindness prevalence of 8.7 percent. A new medical study indicates, however, that with the use of the Macular Health vitamin supplement there is a way to preserve the vision of millions of aging adults suffering from AMD. The second phase of the Multifocal Electroretinogram (MERG) study, conducted at the UAB Callahan Eye Foundation Hospital in Birmingham, Alabama, recently revealed that patients suffering from AMD experienced long-term benefits from taking Macular Health, a special combination of supplemental vitamins, minerals and carotenoids. Phase I of the MERG study, completed in 2005, confirmed an average of 16 percent improvement in vision after taking Macular Health for only 12 weeks. Phase II, completed recently, measured the vision function of the same patients two years later and found an average improvement in vision of 17 percent. Macular Health, LLC


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):